-+ 0.00%
-+ 0.00%
-+ 0.00%

Aclarion secures U.S. patent for AI-based chronic low back pain assessment platform

PUBT·04/16/2026 10:47:30
Listen to the news
Aclarion secures U.S. patent for AI-based chronic low back pain assessment platform
  • Aclarion secured U.S. Patent 12,601,803 covering machine learning-based training and prediction to evaluate pain using magnetic resonance spectroscopy data.
  • Patent supports planned automation in future Nociscan workflows, targeting faster report generation and fewer manual quality reviews.
  • IP portfolio expanded to 64 issued and pending patents worldwide, strengthening competitive positioning in chronic low back pain assessment.
  • Clinical data cited up to 97% surgical success rate when all Nociscan-positive discs are treated alongside other diagnostic tools.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aclarion Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604160647PRIMZONEFULLFEED9691214) on April 16, 2026, and is solely responsible for the information contained therein.